Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2022 | Story André Damons | Photo Jack once productions
The three directors of Epicutis Skincare
All smiles. The three directors of Epicutis Skincare; Dr Maanda Tshikororo, Chief Marketing Officer; Dr Lehlohonolo Makhakhe, Chief Executive officer and primary formulation scientist; and Mrs Mantwa Makhakhe, Chief Operating Officer, showing of some of their new skincare products

A senior lecturer and specialist in the Department of Dermatology at the University of the Free State (UFS) and his two associates, who are also postgraduate students at the university, have realised their dream when they launch their skincare company next month.
 

Dr Lehlohonolo Makhakhe, a full-time medical specialist (dermatologist), Dr Maanda Tshikororo, a medical doctor and a postgraduate student in the Department of Psychiatry, and Mrs Mantwa Makhakhe, who holds a BCom Economics degree and is currently completing her postgraduate diploma in financial planning, are the directors of Epicutis Skincare. Dr Makhakhe, who is also a PhD candidate registered with UFS, is the Chief Executive Officer and primary formulation scientist for the company, while Dr Tshikororo is the Chief Marketing Officer and Mrs Makhakhe the Chief Operating Officer.

The company is launching on 22 October 2022.

Narrowing the gap between treating skin ailments and manufacturing skincare products

According to Dr Makhakhe, who published the very first comprehensive African atlas on skin diseases commonly seen in the African setting,The African Atlas, synopsis and practical guide to clinical dermatology, says Epicutis is a company which will produce a range of personal skincare products. The range will comprise of products such as body lotions, body creams, petroleum jelly and a night cream. Since becoming a dermatologist, he has always wished to narrow the gap between being a clinician treating skin ailments and being involved in manufacturing skincare products.

“Creating products as a dermatologist has great benefits, because the products are created from a clinician’s perspective, with more intentional results. All ingredients used were carefully selected for their specific and scientifically proven benefits, they were then tested for stability in terms of viscosity, pH, microbiology in association with the South African Institute of Dermatology and other third parties,” says Dr Makhakhe. 

Ecstatic about the upcoming launch

Dr Tshikororo says this has been an adventure they have always thought of undertaking. “We finally reached a point of shifting from the comfort of dreaming about it, to taking action.” 

“We hope our company will play a notable role in creating permanent employment for the youth, and also have an impact on the growth of the economy of the Free State province and that of the country as well,” says Mrs Makhakhe. 
The three directors are ecstatic about the upcoming launch of their products, and optimistic that there is enough room for new, affordable, locally manufactured skincare products that are suitable for all family members.  

All products will be available at major retailers soon after the launch. Further information is available at the official website

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept